Webinar Replay: What You Should Know About MDR Best Practices, Including PMCF

On-Demand Webinar

The Medical Device Regulation (MDR) 745/2017, published in 2017, established a stricter and more uniform regulatory framework for the European Union with the goal of improving the clinical safety of the devices. Today, all medical devices in Europe must comply with the MDR yet many companies are still facing difficulties navigating these new regulations. 

In this webinar, sponsored by Alira Health and MassMedic, we review major changes introduced by the MDR. We focus on the post-market requirements, especially the Post-Market Clinical Follow-up (PMCF). Our panel of experts also shares their experiences with the new MDR regulation and offer best practices for companies in the middle of, or about to start, their own MDR journey. 

We can help you navigate PMCF across the entire lifecycle of your MedTech products. 

Published on:
July 12, 2022
The Speakers

Anagha Karnik

Director, Regulatory Affairs, Edwards Lifesciences Anagha has extensive experience in the medical device industry with a proven track record building strong regulatory affairs teams for product development and sustaining manufacturing of Class II and Class III medical devices including cardiovascular, endovascular, IVDs, polymers and has been responsible for bringing several devices to market. Her regulatory experience covers EFS IDEs, pivotal IDEs, Modular PMAs, 510(k)s, CE Marking - MDD Design Dossiers, Technical Files, MDR Technical Documentation (TD), International Dossiers, Clinical Evaluation Reports (CERs), Ad/Promo reviews, product claims/substantiation and market adoption strategies as well as successful domestic and international regulatory authority(ies) interactions and negotiations.

Arthi Chandran

Divisional Vice President, Health Economics and Reimbursement, Abbott Arthi has been a leader in both US and Global roles and is focused on driving public health outcomes while delivering commercial growth in highly competitive markets. In her 15+ year career, in the Medtech and Pharmaceutical industries, Arthi has been recognized for embedding a practice of value demonstration and communication through differentiated evidence generation strategies and accompanying economic tools. She has championed, and continues to drive the proliferation of, cross-functional approaches to innovation and market development to secure broader access to, and adoption of, health care technologies.

Arthi holds an MPH in Chronic Disease Epidemiology from Yale University, an MS in Regulatory Affairs from Temple University and a Doctorate in Health Policy and Management from the City University of New York.

Related news

Publications August 4, 2022
White Paper: New European Health Technology Assessment Regulation
In this white paper, we provide an overview of this new regulation, including key points of the new European Health Technology Assessment Regulation, its methodology, and its timelines.
MedTech Regulatory
Publications July 15, 2022
How to leverage registry-based studies to generate high-quality Real-World Evidence
The use of Real-World Evidence (RWE) in regulatory decision making will support the development and application of better medicines.
Real-World Evidence Registry-based studies Regulatory RWE
Publications July 14, 2022
How to successfully use the EMA IRIS portal to ensure timely submissions
Submitting your scientific advice (SA), orphan drug designation (ODD) or Innovation Task Force (ITF) consultation to the EMA? Avoid delays with our submission recommendations.
European Medicines Agency Orphan Drug Regulatory
Multimedia July 12, 2022
Webinar Replay: What You Should Know About MDR Best Practices, Including PMCF
Discover the major changes introduced by the MDR, including the post-market requirements, and especially the Post-Market Clinical Follow-up (PMCF).
MedTech Regulatory
July 7, 2022
Webinar Replay: Best Practices to Incorporate Diversity and Inclusion in MedTech
Watch this on-demand webinar to gain insight into the topic of diversity and inclusion as it applies across the product lifecycle and more.
Diversity Inclusion MedTech
Events June 30, 2022
DTx France 2022
We are pleased to announce that we will be joining as speakers and exhibitors at DTx France 2022. This hybrid event will focus on the latest DTx trends, regulatory framework, market(...)
DTx trends Market Access Regulatory
Publications June 23, 2022
Developing Data Specialist Talent: Collaboration Is Key
Companies across Pharma and MedTech need talented people to cover the range of data-related challenges. Discover what this means for developing talent throughout the industry.
Data Specialist MedTech Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.